FDA NDC Directory · JSON-LD · Markdown

Docetaxel

NDC 45963-765 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA203551
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsDOCETAXEL (20 mg/mL)
Marketing started20140901
Package count1

External sources

Source: openFDA. Public-domain (CC0).